You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
Mars/Interplanetary Swarm Design and Evaluation Framework (MISDEF)
SBC: ORBIT LOGIC INCORPORATED Topic: T4Addressing the needs of Mars exploration missions in the NASArsquo;s strategic plan will require robust and effective autonomous collaborative operations between heterogeneous assets. These ldquo;swarmsrdquo; may consisting of ground rovers, atmospheric craft and Mars-orbiting satellites. To maximize the satisfaction of overall mission objectives, be tolerant of faults/anomalies, and minimize the ...
STTR Phase I 2019 National Aeronautics and Space Administration -
Autonomous Navigation on Icy Moons and Ocean Worlds
SBC: VETH RESEARCH ASSOCIATES, LLC Topic: T4Technology currently used for terrestrial navigation is extremely limited in the challenging environments on icy moons and ocean worlds such as Europa. Autonomous platforms used to collect data from beneath these ice and ocean surfaces cannot depend on access to satellite or any other electromagnetic communication. Autonomous systems in these environments are required to perform highly-complex tas ...
STTR Phase I 2019 National Aeronautics and Space Administration -
Evaluation of therapeutic efficacy and safety of novel small RNA target delivery platform in vivo.
SBC: Oncoimmune Inc Topic: 100Project Summary AbstractThe recent rapid expansion of genomic data greatly contributes to the understanding of disease development and progressionTo translate these genetic discoveries into clinical applicationswe need to develop therapeutic platforms that can specifically modulate the expression of disease related genes in vivoSmall RNAssuch as microRNAs and siRNAs function in messenger RNA silen ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Coherence Gated Doppler for Dentistry
SBC: Creatv MicroTech, Inc. Topic: NIDCRAbstractIf there were a simple and accurate means totake the pulseof a toothi efunctionally similar to a pulse oximeter that could be clipped on a tooth rather than the tip of a fingerthe quality and cost of dental care would be significantly improvedThe ability to measure dental pulp blood flow provides the most direct means to determine the viability of a tooth and is a vital piece of informatio ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Ultrahigh-Bandwidth Robust Performance Diagnostics for Rotating Detonation Engines
SBC: SPECTRAL ENERGIES LLC Topic: AF19AT011Spectral Energies proposes to design a multisensory diagnostic suite for measurements within elevated-pressure RDEs. This sensor will utilize tunable-laser absorption spectroscopy to measure temperature, pressure and H2O concentrations in the annulus of a rocket-RDE and background-oriented schlieren imaging system for flow density gradient imaging to provide time resolved information about the sho ...
STTR Phase I 2019 Department of DefenseAir Force -
High-Power, Ultra-low Noise, Heterogeneously Integrated Lasers
SBC: Morton Photonics Incorporated Topic: A14AT005In this program, Morton Photonics (MP) and its STTR partner Professor John Bowers and his research group at the University of California at Santa Barbara (UCSB) will develop two truly disruptive integrated laser devices: (1) A broadly tunable integrated laser with ultra-low linewidth, ultra-low relative intensity noise (RIN), and high output power; the Integrated Coherent Tunable Laser (ICTL), whi ...
STTR Phase II 2019 Department of DefenseDefense Advanced Research Projects Agency -
Gallium 68 Tilmanocept for PET Imaging of Atherosclerosis Plaques
SBC: Navidea Biopharmaceuticals, Inc. Topic: NHLBIMyocardial infarctionsMIor heart attacksischemic strokesISand peripheral artery diseasePADtogether considered cardiovascular diseaseCVDare all commonly caused by the same underlying pathologyatherosclerosisMIs and ISs are the leading causes of death and disability worldwideAtherosclerosis is a progressive pathology that develops asymptomatically over the course of many years as inflammatory plaque ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Targeting neurotoxic alpha-synuclein aggregates for Parkinson's disease therapy.
SBC: Vova Ida, LLC Topic: 999SUMMARYParkinsonandapos s diseasePDis the second most prevalent neurodegenerative disorder after Alzheimerandapos s diseaseADaffecting more thanmillion people in the United StatesBecause age is the major risk factorthe prevalence of both diseases is steadily increasing as our population agesPD belongs to the group of protein misfolding neurodegenerative diseases that are due to the misfolding and ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
The Daily Progress System- A Recovery Support Tool to Reduce Health Disparities in Outpatient Substance Use Treatment
SBC: COG ANALYTICS, LLC Topic: 102ABSTRACTSubstance use disordersSUDsincluding opioid use disorderscontinue to be one of the most serious public health issues in the USleading to negative physical and mental health problemsfamily disruptionand premature deathAfrican Americans with drug use histories that are under criminal justice supervision are particularly vulnerable to experiencing the negative consequences associated with SUD ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Gene Therapy to Protect the Lung from Oxidant Stress
SBC: LEXEO Therapeutics LLC Topic: NHLBIAbstractThe focus of this proposal is the development of therapy to protect the lung with an extracellular anti oxidant defense to treat chronic obstructive pulmonary diseaseCOPDa chronic disorder in which inhaled oxidants from tobacco smokepollution and generated within the lung by activated inflammatory cells perpetuate injury to the lung epithelium and endotheliumThe LEXEO strategy is to use in ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health